Is it that hard for someone from the FDA to call PLX during the review process and say "Hey we'd like you guys to send us some more data regarding your testing specifications and assay validation". I'm sure the company would have said it'll be done within the week. This is a huge huge loss for me and one that could easily have been avoided. I'll wait until the meeting with the FDA to sell. GLTA as always.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.